The Variation in Migraine Management in Emergency Departments: Anne-Maree Kelly, MD
January 4th 2022The director of the Joseph Epstein Center for Emergency Medicine Research provided context on the types of research needed to further evaluate and improve diagnosis and management of headache in emergency departments. [WATCH TIME: 3 minutes]
Understanding Cognitive Decline Based on Multiple Sclerosis Phenotype: Dejan Jakimovski, MD, PhD
January 4th 2022The research assistant professor at the Buffalo Neuroimaging Analysis Center provided context on how different forms of multiple sclerosis impact cognitive decline in patients. [WATCH TIME: 3 minutes]
Differentiating Diet Approaches in Multiple Sclerosis: Mona Bostick, RDN, LDN, MSCS
January 3rd 2022The founder of MS Bites discussed the role dietitians can play in care of patients with MS, noting that they have not historically been included in the comprehensive care team, and differentiating their approaches to care. [WATCH TIME: 2 minutes]
Preventing TSC By Treating at the Earliest Stage: Darcy Krueger, MD, PhD
January 3rd 2022The director of the Tuberous Sclerosis Clinic at Cincinnati Children’s discussed the thought behind STOPS2, a trial aimed at preventing or delaying seizure onset in tuberous sclerosis complex. [WATCH TIME: 3 minutes]
Understanding the Causes and Prevalence of Insomnia
A panel of experts break down the myriad of insomnia causes, discussing prevalence amid different patient populations.
CGRP Monoclonal Antibodies and Patient Treatment Selection
Dr Christopher Gottschalk shares how the clinical trial data for CGRP monoclonal antibodies affect patient selection for preventive migraine treatment.
The Effect of Efgartigimod’s Approval on the Myasthenia Gravis Landscape: James F. Howard, MD
December 29th 2021The Distinguished Professor of Neuromuscular Disease at University of North Carolina School of Medicine offered his insight into the newly approved Argenx agent, marketed as Vyvgart. [WATCH TIME: 3 minutes]
Discussing Sleep Medicine Education for Health Professional Trainees: Anita Shelgikar, MD, MHPE
December 28th 2021The clinical associate professor of neurology at the University of Michigan outlined a recent study that assessed the effectiveness of an educational sleep medicine “boot camp.” [WATCH TIME: 2 minutes]
CGRP Monoclonal Antibodies: A Review of Trial Data
A panel of neurologists review clinical trial data on several CGRP monoclonal antibodies for migraine preventive treatment.
Treatment Optimization of Antiseizure Medications, Holding Higher Standards: William Rosenfeld, MD
December 19th 2021The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, provided context on improving our use of current antiseizure medications as the top priority for patients with epilepsy. [WATCH TIME: 2 minutes]